NO20020303L - Flerdose-erytropoietinpreparater - Google Patents

Flerdose-erytropoietinpreparater

Info

Publication number
NO20020303L
NO20020303L NO20020303A NO20020303A NO20020303L NO 20020303 L NO20020303 L NO 20020303L NO 20020303 A NO20020303 A NO 20020303A NO 20020303 A NO20020303 A NO 20020303A NO 20020303 L NO20020303 L NO 20020303L
Authority
NO
Norway
Prior art keywords
dose erythropoietin
dose
erythropoietin
formulations
phenoxyethanol
Prior art date
Application number
NO20020303A
Other languages
English (en)
Other versions
NO20020303D0 (no
Inventor
Atef Gayed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20020303D0 publication Critical patent/NO20020303D0/no
Publication of NO20020303L publication Critical patent/NO20020303L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20020303A 1999-07-22 2002-01-21 Flerdose-erytropoietinpreparater NO20020303L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22
PCT/US2000/040446 WO2001007075A2 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations

Publications (2)

Publication Number Publication Date
NO20020303D0 NO20020303D0 (no) 2002-01-21
NO20020303L true NO20020303L (no) 2002-03-21

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020303A NO20020303L (no) 1999-07-22 2002-01-21 Flerdose-erytropoietinpreparater

Country Status (25)

Country Link
US (1) US7432360B2 (no)
EP (1) EP1200115B9 (no)
JP (1) JP2003517462A (no)
KR (1) KR100693263B1 (no)
CN (2) CN101091792A (no)
AT (1) ATE304863T1 (no)
AU (1) AU777397B2 (no)
BR (1) BR0012667A (no)
CA (1) CA2378945C (no)
CZ (1) CZ302750B6 (no)
DE (1) DE60022759T2 (no)
DK (1) DK1200115T3 (no)
EA (1) EA006220B1 (no)
EE (1) EE200200037A (no)
ES (1) ES2248110T3 (no)
HK (1) HK1050318A1 (no)
HR (1) HRP20020159B1 (no)
HU (1) HUP0202246A3 (no)
IL (2) IL147755A0 (no)
NO (1) NO20020303L (no)
NZ (1) NZ516735A (no)
PL (1) PL202945B1 (no)
RS (1) RS50355B (no)
WO (1) WO2001007075A2 (no)
ZA (1) ZA200200742B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147756A (en) 1999-07-22 2005-12-18 Aventis Pharma Inc Preserved pharmaceutical formulations
BRPI0110914B8 (pt) 2000-05-15 2021-05-25 Hoffmann La Roche 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica'
MXPA06011084A (es) * 2004-03-26 2007-03-21 Johnson & Johnson Regimen de dosificacion en comunicacion para eritropoyetina.
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
DE502006000770D1 (de) * 2005-02-03 2008-06-26 Clariant Produkte Deutschland Konservierungsmittel
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
WO2017068031A1 (en) * 2015-10-22 2017-04-27 Iltoo Pharma Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
WO1995033474A1 (fr) * 1994-06-03 1995-12-14 Tsumura & Co. Composition medicinale
EP0784979A3 (en) * 1996-01-19 1999-03-03 Eli Lilly And Company Obesity protein formulations
BR9712824A (pt) * 1996-09-13 1999-12-21 Advanced Medicine Research Ins Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
IL147755A (en) 2009-11-18
PL353569A1 (en) 2003-12-01
DK1200115T3 (da) 2006-01-16
AU777397B2 (en) 2004-10-14
EE200200037A (et) 2003-04-15
IL147755A0 (en) 2002-08-14
PL202945B1 (pl) 2009-08-31
HRP20020159A2 (en) 2003-06-30
US7432360B2 (en) 2008-10-07
HK1050318A1 (zh) 2003-06-20
ATE304863T1 (de) 2005-10-15
DE60022759D1 (de) 2006-02-02
BR0012667A (pt) 2002-07-02
DE60022759T2 (de) 2006-06-22
HUP0202246A3 (en) 2010-01-28
ES2248110T3 (es) 2006-03-16
ZA200200742B (en) 2003-06-25
WO2001007075A3 (en) 2001-10-04
CA2378945C (en) 2010-02-23
AU7137400A (en) 2001-02-13
CZ2002264A3 (cs) 2002-06-12
NO20020303D0 (no) 2002-01-21
KR20020011143A (ko) 2002-02-07
CA2378945A1 (en) 2001-02-01
EP1200115B9 (en) 2006-01-18
EP1200115A2 (en) 2002-05-02
HRP20020159B1 (en) 2007-08-31
EA200200073A1 (ru) 2002-08-29
EP1200115B1 (en) 2005-09-21
EA006220B1 (ru) 2005-10-27
RS50355B (sr) 2009-11-10
KR100693263B1 (ko) 2007-03-13
JP2003517462A (ja) 2003-05-27
NZ516735A (en) 2004-01-30
HUP0202246A2 (en) 2002-10-28
CN1371284A (zh) 2002-09-25
CN101091792A (zh) 2007-12-26
YU4702A (sh) 2005-06-10
WO2001007075A2 (en) 2001-02-01
US20050267033A1 (en) 2005-12-01
CZ302750B6 (cs) 2011-10-19

Similar Documents

Publication Publication Date Title
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
WO2001034646A3 (en) Recombinant gelatins
ID23374A (id) Halogenopirimidin
DE60036053D1 (de) Erythropoietin Derivate
DE69907145D1 (de) Haarstyling shampoozusammensetzung
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK15098A (da) Retningsbestemt mikrofon, især med symmetrisk retningsvirking
NO20020303D0 (no) Flerdose-erytropoietinpreparater
DE69616074D1 (de) Ara-c derivate
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NO20031673D0 (no) Behandling av kreft
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
DK1173065T3 (da) Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
FR2752699B1 (fr) Boitier, du type boitier de maquillage
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
ES1046207Y (es) Corrector de gesticulacion antiarrugas y antiojeras.
ES1043491Y (es) Mesa redonda de brazos desplegables.
FI981888A0 (fi) Vesipitoisten aineiden esim. uutteiden saattaminen puuhun
FR2772754B1 (fr) Acetals, leurs preparations, leurs utilisations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application